ES2463742T3 - Lector, dispositivo y método de ensayo para medir la HCG - Google Patents
Lector, dispositivo y método de ensayo para medir la HCG Download PDFInfo
- Publication number
- ES2463742T3 ES2463742T3 ES09757809.0T ES09757809T ES2463742T3 ES 2463742 T3 ES2463742 T3 ES 2463742T3 ES 09757809 T ES09757809 T ES 09757809T ES 2463742 T3 ES2463742 T3 ES 2463742T3
- Authority
- ES
- Spain
- Prior art keywords
- analyte
- test
- threshold
- conception
- hcg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000010998 test method Methods 0.000 title claims description 6
- 238000012360 testing method Methods 0.000 claims abstract description 301
- 239000012491 analyte Substances 0.000 claims abstract description 165
- 230000035935 pregnancy Effects 0.000 claims abstract description 49
- 238000005259 measurement Methods 0.000 claims abstract description 45
- 210000002700 urine Anatomy 0.000 claims abstract description 20
- 238000012800 visualization Methods 0.000 claims abstract description 3
- 230000027455 binding Effects 0.000 claims description 145
- 239000003153 chemical reaction reagent Substances 0.000 claims description 134
- 238000001514 detection method Methods 0.000 claims description 117
- 238000003556 assay Methods 0.000 claims description 42
- 239000000020 Nitrocellulose Substances 0.000 claims description 24
- 229920001220 nitrocellulos Polymers 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 18
- 230000002485 urinary effect Effects 0.000 claims description 3
- 238000004458 analytical method Methods 0.000 claims description 2
- 230000001419 dependent effect Effects 0.000 claims 1
- 239000007788 liquid Substances 0.000 description 42
- 230000035945 sensitivity Effects 0.000 description 40
- 239000000463 material Substances 0.000 description 28
- 239000004816 latex Substances 0.000 description 21
- 229920000126 latex Polymers 0.000 description 21
- 102000009151 Luteinizing Hormone Human genes 0.000 description 20
- 108010073521 Luteinizing Hormone Proteins 0.000 description 20
- 229940040129 luteinizing hormone Drugs 0.000 description 20
- 239000011152 fibreglass Substances 0.000 description 19
- 239000003550 marker Substances 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 230000003287 optical effect Effects 0.000 description 16
- 238000003239 susceptibility assay Methods 0.000 description 15
- 230000027758 ovulation cycle Effects 0.000 description 12
- 239000002245 particle Substances 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- 238000003018 immunoassay Methods 0.000 description 11
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 10
- 229940098773 bovine serum albumin Drugs 0.000 description 10
- 238000004422 calculation algorithm Methods 0.000 description 10
- 238000011161 development Methods 0.000 description 10
- 230000018109 developmental process Effects 0.000 description 10
- 239000011148 porous material Substances 0.000 description 9
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- -1 haptens Chemical class 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- 239000004372 Polyvinyl alcohol Substances 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 230000016087 ovulation Effects 0.000 description 7
- 229920002451 polyvinyl alcohol Polymers 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 241000894007 species Species 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 6
- 230000000903 blocking effect Effects 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 230000029849 luteinization Effects 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 229920002223 polystyrene Polymers 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 239000005720 sucrose Substances 0.000 description 6
- 239000004793 Polystyrene Substances 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 230000011599 ovarian follicle development Effects 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 238000004088 simulation Methods 0.000 description 5
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 4
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 229940028334 follicle stimulating hormone Drugs 0.000 description 4
- 230000003821 menstrual periods Effects 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 239000000186 progesterone Substances 0.000 description 4
- 229960003387 progesterone Drugs 0.000 description 4
- 239000001632 sodium acetate Substances 0.000 description 4
- 235000017281 sodium acetate Nutrition 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000004743 Polypropylene Substances 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 210000004246 corpus luteum Anatomy 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 3
- 230000003054 hormonal effect Effects 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 230000003100 immobilizing effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 229920009537 polybutylene succinate adipate Polymers 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000002787 reinforcement Effects 0.000 description 3
- 239000013049 sediment Substances 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000010200 validation analysis Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical group N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 229920002799 BoPET Polymers 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 102000011923 Thyrotropin Human genes 0.000 description 2
- 108010061174 Thyrotropin Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 2
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000001680 brushing effect Effects 0.000 description 2
- 229920002678 cellulose Chemical class 0.000 description 2
- 239000001913 cellulose Chemical class 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 210000004696 endometrium Anatomy 0.000 description 2
- 229960005309 estradiol Drugs 0.000 description 2
- 229930182833 estradiol Natural products 0.000 description 2
- 239000003365 glass fiber Substances 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 238000012125 lateral flow test Methods 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 210000004681 ovum Anatomy 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 238000000159 protein binding assay Methods 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 238000009827 uniform distribution Methods 0.000 description 2
- CXCHEKCRJQRVNG-UHFFFAOYSA-N 2,2,2-trifluoroethanesulfonyl chloride Chemical compound FC(F)(F)CS(Cl)(=O)=O CXCHEKCRJQRVNG-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 108090001008 Avidin Chemical group 0.000 description 1
- 108020004635 Complementary DNA Chemical group 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 108090001090 Lectins Chemical group 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 239000005041 Mylar™ Substances 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 206010036049 Polycystic ovaries Diseases 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229940096437 Protein S Drugs 0.000 description 1
- 108010066124 Protein S Proteins 0.000 description 1
- 102000029301 Protein S Human genes 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229920006221 acetate fiber Chemical class 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000001720 carbohydrates Chemical group 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012412 chemical coupling Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229940124558 contraceptive agent Drugs 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- AJFXNBUVIBKWBT-UHFFFAOYSA-N disodium;boric acid;hydrogen borate Chemical compound [Na+].[Na+].OB(O)O.OB(O)O.OB(O)O.OB([O-])[O-] AJFXNBUVIBKWBT-UHFFFAOYSA-N 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 210000004996 female reproductive system Anatomy 0.000 description 1
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000003698 laser cutting Methods 0.000 description 1
- 239000002523 lectin Chemical group 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000029860 luteolysis Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 210000002394 ovarian follicle Anatomy 0.000 description 1
- MTZWHHIREPJPTG-UHFFFAOYSA-N phorone Chemical compound CC(C)=CC(=O)C=C(C)C MTZWHHIREPJPTG-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920002102 polyvinyl toluene Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000006259 progesterone secretion Effects 0.000 description 1
- 230000035752 proliferative phase Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000013179 statistical model Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 229910052714 tellurium Inorganic materials 0.000 description 1
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical compound [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/84—Systems specially adapted for particular applications
- G01N21/8483—Investigating reagent band
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/84—Systems specially adapted for particular applications
- G01N21/8483—Investigating reagent band
- G01N2021/8488—Investigating reagent band the band presenting reference patches
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0810142 | 2008-06-04 | ||
| GB0810142.0A GB2460660B (en) | 2008-06-04 | 2008-06-04 | Assay reader device & method for measuring hCG |
| PCT/GB2009/050619 WO2009147437A1 (en) | 2008-06-04 | 2009-06-03 | Assay reader, device and method for measuring hcg |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2463742T3 true ES2463742T3 (es) | 2014-05-29 |
Family
ID=39638107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES09757809.0T Active ES2463742T3 (es) | 2008-06-04 | 2009-06-03 | Lector, dispositivo y método de ensayo para medir la HCG |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9851364B2 (enExample) |
| EP (1) | EP2294427B1 (enExample) |
| JP (1) | JP5386577B2 (enExample) |
| CN (1) | CN102105795B (enExample) |
| AU (1) | AU2009254934B2 (enExample) |
| CA (1) | CA2726739C (enExample) |
| ES (1) | ES2463742T3 (enExample) |
| GB (1) | GB2460660B (enExample) |
| NZ (1) | NZ589488A (enExample) |
| WO (1) | WO2009147437A1 (enExample) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9173661B2 (en) | 2006-02-27 | 2015-11-03 | Biomet Manufacturing, Llc | Patient specific alignment guide with cutting surface and laser indicator |
| US9289253B2 (en) | 2006-02-27 | 2016-03-22 | Biomet Manufacturing, Llc | Patient-specific shoulder guide |
| US9345548B2 (en) | 2006-02-27 | 2016-05-24 | Biomet Manufacturing, Llc | Patient-specific pre-operative planning |
| US8422740B2 (en) * | 2009-01-15 | 2013-04-16 | Scott Dylewski | Methods for determining a liquid front position on a test strip |
| AT509727B1 (de) * | 2010-08-13 | 2011-11-15 | Scheuringer Kim | Kit umfassend eine testvorrichtung |
| US8828329B2 (en) | 2010-10-01 | 2014-09-09 | Church & Dwight, Co., Inc. | Electronic analyte assaying device |
| US20130001121A1 (en) | 2011-07-01 | 2013-01-03 | Biomet Manufacturing Corp. | Backup kit for a patient-specific arthroplasty kit assembly |
| CN102384890B (zh) * | 2011-08-05 | 2014-04-30 | 广州万孚生物技术股份有限公司 | 化验检测判定设备及方法 |
| WO2013036913A1 (en) * | 2011-09-08 | 2013-03-14 | Nexus Dx, Inc. | A multilevel analyte assay |
| WO2013062848A1 (en) | 2011-10-27 | 2013-05-02 | Biomet Manufacturing Corporation | Patient-specific glenoid guides |
| US9451973B2 (en) | 2011-10-27 | 2016-09-27 | Biomet Manufacturing, Llc | Patient specific glenoid guide |
| US9301812B2 (en) | 2011-10-27 | 2016-04-05 | Biomet Manufacturing, Llc | Methods for patient-specific shoulder arthroplasty |
| CN103163305B (zh) * | 2011-12-19 | 2014-11-12 | 天津中新科炬生物制药有限公司 | 一种快速判断女性妊娠情况的方法 |
| CN102565426A (zh) * | 2011-12-22 | 2012-07-11 | 正元盛邦(天津)生物科技有限公司 | 用双指示线免疫层析半定量诊断促黄体生成素的方法 |
| US9588113B2 (en) | 2012-02-22 | 2017-03-07 | Church & Dwight Co., Inc. | Methods for electronic analyte assaying |
| US9207181B2 (en) * | 2012-03-01 | 2015-12-08 | Quidel Corporation | System and apparatus for point-of-care diagnostics |
| AU2013225728B2 (en) | 2012-03-01 | 2018-07-26 | Ortho-Clinical Diagnostics, Inc. | Interactive test device and apparatus with timing mechanism |
| ES2681241T3 (es) * | 2012-09-27 | 2018-09-12 | Ellume Pty Ltd. | Dispositivos y procedimientos de diagnóstico |
| US9839438B2 (en) | 2013-03-11 | 2017-12-12 | Biomet Manufacturing, Llc | Patient-specific glenoid guide with a reusable guide holder |
| US9826981B2 (en) | 2013-03-13 | 2017-11-28 | Biomet Manufacturing, Llc | Tangential fit of patient-specific guides |
| AU2013382020B2 (en) | 2013-03-14 | 2018-08-30 | Hollister Incorporated | Compact urinary catheters and methods for making the same |
| KR101562946B1 (ko) * | 2013-04-23 | 2015-10-26 | 주식회사 수젠텍 | 검체 내 분석물을 검출하기 위한 디바이스 및 방법 |
| CN105555318A (zh) * | 2013-07-18 | 2016-05-04 | 香港大学 | 将胸膜液分类的方法 |
| GB201317458D0 (en) | 2013-10-02 | 2013-11-13 | Spd Swiss Prec Diagnostics Gmbh | Improved pregnancy test device and method |
| US20150112349A1 (en) | 2013-10-21 | 2015-04-23 | Biomet Manufacturing, Llc | Ligament Guide Registration |
| US9989466B2 (en) | 2013-12-06 | 2018-06-05 | Quidel Corporation | Method for reducing analyzer variability using a normalization target |
| US9962265B2 (en) * | 2014-03-07 | 2018-05-08 | Arthrosurface Incorporated | System and method for repairing articular surfaces |
| US20180306815A1 (en) * | 2014-11-18 | 2018-10-25 | Siemens Healthcare Diagnostics Inc. | Lateral flow assay ratio test |
| TWM503197U (zh) * | 2014-12-31 | 2015-06-21 | Yonglin Yonglin Biotech Corp | 生理檢測裝置 |
| TW201626319A (zh) * | 2015-01-05 | 2016-07-16 | 永齡生技股份有限公司 | 生理週期預測雲端系統及方法 |
| CA2979864A1 (en) * | 2015-03-23 | 2016-09-29 | Wellmetris, Llc | Smartphone enabled urinalysis device, software, and test platform |
| US10794920B2 (en) | 2015-04-02 | 2020-10-06 | Spd Swiss Precision Diagnostics Gmbh | Pregnancy test device and method |
| WO2016196347A1 (en) * | 2015-05-29 | 2016-12-08 | Polymer Technology Systems, Inc. | Systems and methods for combined vertical/lateral flow blood separation technologies with cotinine detection |
| JP6595818B2 (ja) * | 2015-06-30 | 2019-10-23 | 田中貴金属工業株式会社 | 免疫クロマト分析装置及び免疫クロマト分析方法 |
| CN111566228A (zh) | 2017-10-23 | 2020-08-21 | 陈扎克伯格生物中心公司 | 用于在胎儿孕育中预测胎龄和早产的无创分子钟 |
| CN108387749A (zh) * | 2018-03-07 | 2018-08-10 | 广州浩强生物科技有限公司 | 一种或受孕的检测方法及检测笔 |
| CN108519489A (zh) * | 2018-03-26 | 2018-09-11 | 南通伊仕生物技术股份有限公司 | 一种电子检测笔及早孕孕周数检测方法 |
| EP3830570A4 (en) * | 2018-07-27 | 2021-11-03 | Lumos Diagnostics IP PTY LTD | SIDE-FLOW METERING DEVICES AND METHOD OF USE |
| CN109444413B (zh) * | 2018-09-26 | 2019-08-27 | 深圳市疾病预防控制中心（深圳市卫生检验中心、深圳市预防医学研究所） | 一种检测装置 |
| KR102843656B1 (ko) | 2019-06-14 | 2025-08-08 | 드라발 홀딩 에이비 | 측방 유동 테스트 결과의 유효성을 결정하기 위한 시스템 |
| KR102346178B1 (ko) * | 2019-12-16 | 2022-01-03 | (주)프로테옴텍 | 면역 크로마토그래피용 스트립, 키트 및 이를 이용하는 경쟁적 면역 크로마토그래피 분석 방법 |
| EP3940335A1 (en) * | 2020-07-15 | 2022-01-19 | ams AG | Self-mixing interferferometry for absorption or color detection and application in lateral flow testing |
| US12105099B2 (en) * | 2021-04-28 | 2024-10-01 | Diotex Diagnostics, Llc | Methods and devices for quantitatively estimating syndecan-1 |
| GB202404646D0 (en) * | 2024-04-02 | 2024-05-15 | Flexotronix Ltd | Diagnostic device |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5026653A (en) | 1985-04-02 | 1991-06-25 | Leeco Diagnostic, Inc. | Scavenger antibody mixture and its use for immunometric assay |
| ES2150428T3 (es) | 1987-04-27 | 2000-12-01 | Unilever Nv | Ensayos de union especifica. |
| IT1227293B (it) * | 1988-10-06 | 1991-04-05 | Boehringer Biochemia Srl | Dispositivo e metodo per la diagnosi di gravidanza |
| US6352862B1 (en) | 1989-02-17 | 2002-03-05 | Unilever Patent Holdings B.V. | Analytical test device for imuno assays and methods of using same |
| ES2092523T3 (es) | 1990-05-09 | 1996-12-01 | Abbott Lab | Ensayos que utilizan enlaces con recuperacion de conjugado. |
| US5158869A (en) | 1990-07-06 | 1992-10-27 | Sangstat Medical Corporation | Analyte determination using comparison of juxtaposed competitive and non-competitive elisa results and device therefore |
| US5955377A (en) | 1991-02-11 | 1999-09-21 | Biostar, Inc. | Methods and kits for the amplification of thin film based assays |
| JPH04351962A (ja) * | 1991-05-29 | 1992-12-07 | Mochida Pharmaceut Co Ltd | 特異結合分析方法および特異結合分析装置 |
| JP2976652B2 (ja) * | 1991-11-18 | 1999-11-10 | 東陶機器株式会社 | バイオセンサ |
| DE4202850A1 (de) | 1992-01-31 | 1993-08-05 | Boehringer Mannheim Gmbh | Analysenelement fuer immunoassays |
| US5707818A (en) | 1994-12-13 | 1998-01-13 | Bsi Corporation | Device and method for simultaneously performing multiple competitive immunoassays |
| US5731212A (en) | 1994-12-20 | 1998-03-24 | International Technidyne Corporation | Test apparatus and method for testing cuvette accommodated samples |
| AU6720096A (en) | 1995-08-09 | 1997-03-05 | Quidel Corporation | Test strip and method for one step lateral flow assay |
| US7635597B2 (en) | 1995-08-09 | 2009-12-22 | Bayer Healthcare Llc | Dry reagent particle assay and device having multiple test zones and method therefor |
| US5981298A (en) | 1995-12-13 | 1999-11-09 | Surmodics, Inc. | Immunoassay device and method |
| US5998221A (en) | 1996-09-25 | 1999-12-07 | Becton, Dickinson And Company | Non-instrumented assay with quantitative and qualitative results |
| GB9700759D0 (en) | 1997-01-15 | 1997-03-05 | Carbury Herne Limited | Assay device |
| US6924153B1 (en) * | 1997-03-06 | 2005-08-02 | Quidel Corporation | Quantitative lateral flow assays and devices |
| AU8489698A (en) | 1997-07-16 | 1999-02-10 | Charm Sciences, Inc. | A test device and method for detecting the presence of a residue analyte in a sample |
| US20060019404A1 (en) | 1998-05-06 | 2006-01-26 | Blatt Joel M | Quantitative assay with extended dynamic range |
| GB2339615B (en) | 1998-07-14 | 2001-02-07 | Cozart Bioscience Ltd | Screening device and method of screening an immunoassay test |
| US6214629B1 (en) | 1998-08-06 | 2001-04-10 | Spectral Diagnostics, Inc. | Analytical test device and method for use in medical diagnoses |
| US6297020B1 (en) | 1999-03-01 | 2001-10-02 | Bayer Corporation | Device for carrying out lateral-flow assays involving more than one analyte |
| US6656745B1 (en) | 2000-06-02 | 2003-12-02 | Francis X. Cole | Devices and methods for a multi-level, semi-quantitative immunodiffusion assay |
| US20020123671A1 (en) * | 2000-08-31 | 2002-09-05 | Haaland Peter D. | Method and apparatus for monitoring biological properties |
| GB0103755D0 (en) * | 2001-02-15 | 2001-04-04 | Genosis Ltd | Urine assay |
| US20040018576A1 (en) | 2002-07-24 | 2004-01-29 | Dematteo Todd M. | Bence Jones protein testing cassette |
| WO2004021004A1 (en) | 2002-08-27 | 2004-03-11 | Kimberly-Clark Worldwide, Inc. | Membrane-based assays using time-resolved fluorescence |
| AU2003277309A1 (en) * | 2002-10-08 | 2004-05-04 | Tara Nylese | Portable diagnostic device and method for determining temporal variations in concentrations |
| US7781172B2 (en) | 2003-11-21 | 2010-08-24 | Kimberly-Clark Worldwide, Inc. | Method for extending the dynamic detection range of assay devices |
| FI118904B (fi) | 2003-03-28 | 2008-04-30 | Ani Biotech Oy | Monikanavainen testiväline, menetelmä sen valmistamiseksi ja sen käyttö |
| DE10314634A1 (de) | 2003-04-01 | 2004-10-14 | Khs Maschinen- Und Anlagenbau Ag, Patentabteilung | Spülbares Huborgan |
| US7851209B2 (en) | 2003-04-03 | 2010-12-14 | Kimberly-Clark Worldwide, Inc. | Reduction of the hook effect in assay devices |
| US7315378B2 (en) * | 2003-06-04 | 2008-01-01 | Inverness Medical Switzerland Gmbh | Optical arrangement for assay reading device |
| GB2402474A (en) | 2003-06-04 | 2004-12-08 | Inverness Medical Switzerland | Analyte assay reading device having unequal numbers of photodetectors and test-strip zones |
| CA2468014C (en) * | 2003-06-04 | 2016-03-22 | Inverness Medical Switzerland Gmbh | Flow sensing for determination of assay results |
| EP1484601B1 (en) | 2003-06-04 | 2009-02-04 | Inverness Medical Switzerland GmbH | Optical arrangement for assay reading device |
| US7239394B2 (en) * | 2003-06-04 | 2007-07-03 | Inverness Medical Switzerland Gmbh | Early determination of assay results |
| EP1484641A1 (en) | 2003-06-06 | 2004-12-08 | Agfa-Gevaert | Binders for use in the thermosensitive elements of substantially light-insensitive thermographic recording materials. |
| DE10330982A1 (de) | 2003-07-09 | 2005-02-17 | Prisma Diagnostika Gmbh | Vorrichtung und Verfahren zur simultanen Bestimmung von Blutgruppenantigenen |
| EP1664781B1 (en) | 2003-09-22 | 2013-05-08 | Quidel Corporation | Devices for the detection of multiple analytes in a sample |
| US7713748B2 (en) | 2003-11-21 | 2010-05-11 | Kimberly-Clark Worldwide, Inc. | Method of reducing the sensitivity of assay devices |
| US7943395B2 (en) | 2003-11-21 | 2011-05-17 | Kimberly-Clark Worldwide, Inc. | Extension of the dynamic detection range of assay devices |
| ES2332523T3 (es) | 2004-02-09 | 2010-02-08 | Rapid Pathogen Screening Inc. | Metodo para el diagnostico rapido de blancos en fluidos corporales humanos. |
| EP1571451A1 (en) * | 2004-03-05 | 2005-09-07 | Inverness Medical Switzerland GmbH | Method and apparatus for estimating due date |
| US20050196812A1 (en) * | 2004-03-05 | 2005-09-08 | Williams David E. | Determining the estimated date of embryo implantation and related dates |
| US20050208593A1 (en) | 2004-03-19 | 2005-09-22 | Arizona Board Of Regents, Acting For And On Behalf Of Northern Arizona University | Lateral flow diagnostic assay reader with radial cassette |
| US7521259B2 (en) | 2004-04-01 | 2009-04-21 | Alverix, Inc. | Assay test strips with multiple labels and reading same |
| EP1657550A1 (en) | 2004-11-10 | 2006-05-17 | Coris Bioconcept SPRL | Double-sided device for multiplex dipstick immunodiagnostic |
| EP1866652A1 (en) * | 2005-03-24 | 2007-12-19 | Inverness Medical Switzerland GmbH | Determining the estimated date of embryo implantation and related dates |
| US20060246599A1 (en) | 2005-04-29 | 2006-11-02 | Sarah Rosenstein | Lateral flow device |
| US7871781B2 (en) | 2005-05-23 | 2011-01-18 | Phadia Ab | Two step lateral flow assay methods and devices |
| GB0516099D0 (en) * | 2005-08-05 | 2005-09-14 | Cambridge Diagnostics Ireland | Assay reading device with display |
| US20070081920A1 (en) | 2005-10-12 | 2007-04-12 | Murphy R S | Semi-disposable optoelectronic rapid diagnostic test system |
| US7989217B2 (en) | 2007-03-29 | 2011-08-02 | Ameritek Usa, Inc. | Method for determining hCG levels in fluid samples |
| GB0717043D0 (en) * | 2007-04-10 | 2007-10-10 | Inverness Medical Switzerland | Assay device |
| GB2450351B (en) | 2007-06-20 | 2012-01-18 | Cozart Bioscience Ltd | Monitoring an Immunoassay |
| AU2008207371B2 (en) | 2007-09-01 | 2014-05-22 | Abbott Rapid Diagnostics International Unlimited Company | Assay device with shared zones |
| US20100129935A1 (en) * | 2008-11-25 | 2010-05-27 | Sarah Daniel Maddison | Pregnancy testing method |
-
2008
- 2008-06-04 GB GB0810142.0A patent/GB2460660B/en active Active
-
2009
- 2009-06-03 EP EP09757809.0A patent/EP2294427B1/en active Active
- 2009-06-03 WO PCT/GB2009/050619 patent/WO2009147437A1/en not_active Ceased
- 2009-06-03 ES ES09757809.0T patent/ES2463742T3/es active Active
- 2009-06-03 JP JP2011512220A patent/JP5386577B2/ja active Active
- 2009-06-03 NZ NZ589488A patent/NZ589488A/xx unknown
- 2009-06-03 AU AU2009254934A patent/AU2009254934B2/en active Active
- 2009-06-03 CA CA2726739A patent/CA2726739C/en active Active
- 2009-06-03 US US12/996,197 patent/US9851364B2/en active Active
- 2009-06-03 CN CN200980128973.0A patent/CN102105795B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| GB2460660A (en) | 2009-12-09 |
| GB2460660B (en) | 2013-05-22 |
| JP5386577B2 (ja) | 2014-01-15 |
| CA2726739C (en) | 2017-10-17 |
| CN102105795B (zh) | 2015-05-13 |
| GB0810142D0 (en) | 2008-07-09 |
| US20120021531A1 (en) | 2012-01-26 |
| EP2294427B1 (en) | 2014-03-12 |
| WO2009147437A1 (en) | 2009-12-10 |
| AU2009254934A1 (en) | 2009-12-10 |
| NZ589488A (en) | 2013-07-26 |
| AU2009254934B2 (en) | 2015-11-26 |
| CN102105795A (zh) | 2011-06-22 |
| US9851364B2 (en) | 2017-12-26 |
| EP2294427A1 (en) | 2011-03-16 |
| CA2726739A1 (en) | 2009-12-10 |
| JP2011522272A (ja) | 2011-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2463742T3 (es) | Lector, dispositivo y método de ensayo para medir la HCG | |
| ES2438272T3 (es) | Dispositivo de ensayo | |
| EP2469269B1 (en) | Assay device with shared zones | |
| CN102099678B (zh) | 化验装置 | |
| JP6675976B2 (ja) | 改善された妊娠検査デバイスおよび方法 | |
| CN108139410A (zh) | 改进的怀孕测试装置及方法 | |
| HK1167715B (en) | Assay device with shared zones |